Literature DB >> 14636435

[An epidemiological survey of alcoholic liver disease in Zhejiang province].

You-ming Li1, Wei-xing Chen, Chao-hui Yu, Min Yue, You-shi Liu, Gen-yu Xu, Feng Ji, Su-dan Li.   

Abstract

OBJECTIVE: To describe the brief survey of alcohol intake and the incidence of alcohol liver disease in Zhejiang province.
METHODS: 18,237 requested persons aged over 18 years were selected by multi-stage stratified cluster sampling in Zhejiang province. Questionnaire about alcohol consumption, hepatic ultrasonic scan and detection of hepatic enzymes and markers of HBV and HCV were carried out. Daily alcohol intake more than 40g (including equal to 40g/d) was essential for the diagnosis of alcoholic liver disease.
RESULTS: Among the 18,237 persons (male 12,042, female 6195), the average daily alcohol intake was (17.7 +/- 27.2) g. The incidence of alcoholic liver disease in Zhejiang province was 4.34% (male 6.36%, female 0.36%) in the whole population. Four subtypes were separated as alcoholic cirrhosis, alcoholic fat liver, alcoholic hepatitis and mild alcoholic injury in liver with the corresponding incidence of 0.68%, 0.94%, 1.51% and 1.21% separately.
CONCLUSION: Alcoholic liver disease is found to be a common disease in Zhejiang province, indicating an urgent need for the public education on alcohol abuse and the treatment on related health problems

Entities:  

Mesh:

Year:  2003        PMID: 14636435

Source DB:  PubMed          Journal:  Zhonghua Gan Zang Bing Za Zhi        ISSN: 1007-3418


  7 in total

Review 1.  Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.

Authors:  Shiv K Sarin; Manoj Kumar; Mohammed Eslam; Jacob George; Mamun Al Mahtab; Sheikh M Fazle Akbar; Jidong Jia; Qiuju Tian; Rakesh Aggarwal; David H Muljono; Masao Omata; Yoshihiko Ooka; Kwang-Hyub Han; Hye Won Lee; Wasim Jafri; Amna S Butt; Chern H Chong; Seng G Lim; Raoh-Fang Pwu; Ding-Shinn Chen
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-12-15

2.  Risk factors for alcohol-related liver injury in the island population of China: a population-based case-control study.

Authors:  Zhe Shen; You-Ming Li; Chao-Hui Yu; Yi Shen; Lei Xu; Cheng-Fu Xu; Jin-Jin Chen; Hua Ye; Gen-Yun Xu
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

3.  Prevalence and risk factors of fatty liver disease in the Shuiguohu district of Wuhan city, central China.

Authors:  Zhongli Wang; Bing Xia; Chunwei Ma; Zhengguo Hu; Xiangqun Chen; Ping Cao
Journal:  Postgrad Med J       Date:  2007-03       Impact factor: 2.401

4.  Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B.

Authors:  Xi Jin; Yi-peng Chen; Yi-da Yang; You-ming Li; Lin Zheng; Chuan-qing Xu
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

5.  Changes in Etiologies of Hospitalized Patients with Liver Cirrhosis in Beijing 302 Hospital from 2002 to 2013.

Authors:  Binxia Chang; Baosen Li; Ying Sun; Guangju Teng; Ang Huang; Jin Li; Zhengsheng Zou
Journal:  Mediators Inflamm       Date:  2017-11-19       Impact factor: 4.711

6.  A cross-sectional study of alcohol consumption and alcoholic liver disease in Beijing: based on 74,998 community residents.

Authors:  Huai Wang; Pei Gao; Weixin Chen; Qianli Yuan; Min Lv; Shuang Bai; Jiang Wu
Journal:  BMC Public Health       Date:  2022-04-12       Impact factor: 3.295

7.  The transition of alcohol control in China 1990-2019: Impacts and recommendations.

Authors:  Aqian Hu; Heng Jiang; Rowan Dowling; Lei Guo; Xiaoxi Zhao; Wei Hao; Xiaojun Xiang
Journal:  Int J Drug Policy       Date:  2022-04-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.